JAX Antibody Development Summit - Geoff Hale
Dr. Geoff Hale, CEO, mAbsolve, presents Characterisation of Novel Antibodies Which are Completely Silenced with Respect to Fc Binding Function as part of The Jackson Laboratory's Antibody Drug Development Summit.